首页> 外文期刊>Phytotherapy research: PTR >Zerumbone Suppresses IL-1β-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells
【24h】

Zerumbone Suppresses IL-1β-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells

机译:Zerumbone通过抑制人三阴性乳腺癌细胞中的IL-8和MMP-3表达来抑制IL-1β诱导的细胞迁移和侵袭。

获取原文
获取原文并翻译 | 示例
           

摘要

Inflammation is a key regulatory process in cancer development. Prolonged exposure of breast tumor cells to inflammatory cytokines leads to epithelial-mesenchymal transition, which is the principal mechanism involved in metastasis and tumor invasion. Interleukin (IL)-1β is a major inflammatory cytokine in a variety of tumors. To date, the regulatory mechanism of IL-1β-induced cell migration and invasion has not been fully elucidated. Here, we investigated the effect of zerumbone (ZER) on IL-1β-induced cell migration and invasion in breast cancer cells. The levels of IL-8 and matrix metalloproteinase (MMP)-3 mRNA were analyzed by real-time polymerase chain reaction. The levels of secreted IL-8 and MMP-3 protein were analyzed by enzyme-linked immunosorbent assay and western blot analysis, respectively. Cell invasion and migration was detected by Boyden chamber assay. The levels of IL-8 and MMP-3 expression were significantly increased by IL-1β treatment in Hs578T and MDA-MB231 cells. On the other hand, IL-1β-induced IL-8 and MMP-3 expression was decreased by ZER. Finally, IL-1β-induced cell migration and invasion were decreased by ZER in Hs578T and MDA-MB231 cells. ZER suppresses IL-1β-induced cell migration and invasion by inhibiting IL-8 expression and MMP-3 expression in TNBC cells. ZER could be a promising therapeutic drug for treatment of triplenegative breast cancer patients
机译:炎症是癌症发展中的关键调控过程。乳腺肿瘤细胞长时间暴露于炎性细胞因子会导致上皮-间质转化,这是参与转移和肿瘤侵袭的主要机制。白介素(IL)-1β是多种肿瘤中的主要炎症细胞因子。迄今为止,尚未完全阐明IL-1β诱导的细胞迁移和侵袭的调节机制。在这里,我们研究了zerumbone(ZER)对IL-1β诱导的乳腺癌细胞迁移和侵袭的影响。通过实时聚合酶链反应分析IL-8和基质金属蛋白酶(MMP)-3 mRNA的水平。分别通过酶联免疫吸附测定和蛋白质印迹分析来分析分泌的IL-8和MMP-3蛋白的水平。通过Boyden室测定法检测细胞的侵袭和迁移。通过IL-1β处理,Hs578T和MDA-MB231细胞中IL-8和MMP-3的表达水平显着增加。另一方面,ZER降低了IL-1β诱导的IL-8和MMP-3表达。最后,ZER减少了Hs578T和MDA-MB231细胞中IL-1β诱导的细胞迁移和侵袭。 ZER通过抑制TNBC细胞中IL-8表达和MMP-3表达来抑制IL-1β诱导的细胞迁移和侵袭。 ZER可能是治疗三阴性乳腺癌患者的有前途的治疗药物

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号